23rd Annual Meeting – of the working group “Experimental Neuro-Oncology”

Abstracts (HTML) List of Authors

Abel, U

Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

Agostinis, P

Irradiation of freeze-thaw lysate used to pulse dendritic cells further increases antitumor immunity in a mouse model of high-grade glioma

Arnaiz, P

HDAC10: a novel drug target for childhood tumors of the nervous system

Baldi, C

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Bartsch, JW

Cell surface metalloproteases as targets in glioblastoma: implications for tumor growth and therapy resistance

Beullens, M

Irradiation of freeze-thaw lysate used to pulse dendritic cells further increases antitumor immunity in a mouse model of high-grade glioma

Bueren, AO von

Phosphoproteomic Analysis of Glioblastoma Reveals Distinct Molecular Subclasses Defined by CREB, NOTCH1 and GSK3b and Different Overall Survival
Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Burhenne, J

Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

Buttarelli, FR

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Capper, D

INFORM: personalized pediatric oncology enters the clinic

Classen, CF

Analysis and applicability of different in vitro models of Glioblastoma multiforme

Conrad, C

Cell surface metalloproteases as targets in glioblastoma: implications for tumor growth and therapy resistance

Deimling, A von

INFORM: personalized pediatric oncology enters the clinic
Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

Deubzer, HE

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

De Vleeschouwer, S

Immunotherapy for children and adults with malignant glioma, the Leuven experiences

Doerner, E

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Dong, F

Cell surface metalloproteases as targets in glioblastoma: implications for tumor growth and therapy resistance

Ecker, J

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

Eckhardt, I

Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB

Eggert, A

INFORM: personalized pediatric oncology enters the clinic

Eibach, M

Cell surface metalloproteases as targets in glioblastoma: implications for tumor growth and therapy resistance

Eisenmenger, A

Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

Erdlenbruch, B

Editorial

Figarella-Branger, D

Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB

Fulda, S

Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB
MCP-1 – a critical inducer of Smac mimetic-induced migration and invasion in glioma cells

Garg, A

Irradiation of freeze-thaw lysate used to pulse dendritic cells further increases antitumor immunity in a mouse model of high-grade glioma

Gessi, M

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Giangaspero, F

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Gielen, GH

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Glasow, A

Enhancement of radiation effects by combined treatment with 5-aza-2'-deoxycytidine and differentiation-inducing or epigenetic drugs in human MB cells

Hammes, J

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Hutter, G

Phosphoproteomic Analysis of Glioblastoma Reveals Distinct Molecular Subclasses Defined by CREB, NOTCH1 and GSK3b and Different Overall Survival

Jennewein, C

Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB

Jones, DT

INFORM: personalized pediatric oncology enters the clinic

Josupeit, R

Treatment approaches combining cytostatic drugs with the oncolytic parvovirus H-1 increase cytotoxic effects in cell culture models of highly malignant pediatric brain tumors

Karapanagiotou-Schenkel, I

Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

Koeneke, E

HDAC10: a novel drug target for childhood tumors of the nervous system

Koks, C

Irradiation of freeze-thaw lysate used to pulse dendritic cells further increases antitumor immunity in a mouse model of high-grade glioma

Kool, M

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

Korshunov, A

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

Kortmann, RD

Enhancement of radiation effects by combined treatment with 5-aza-2'-deoxycytidine and differentiation-inducing or epigenetic drugs in human MB cells

Kramm, CM

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Kulozik, AE

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

Lacroix, J

Treatment approaches combining cytostatic drugs with the oncolytic parvovirus H-1 increase cytotoxic effects in cell culture models of highly malignant pediatric brain tumors

Leu, S

Phosphoproteomic Analysis of Glioblastoma Reveals Distinct Molecular Subclasses Defined by CREB, NOTCH1 and GSK3b and Different Overall Survival

Leuchs, B

Treatment approaches combining cytostatic drugs with the oncolytic parvovirus H-1 increase cytotoxic effects in cell culture models of highly malignant pediatric brain tumors

Lichter, P

INFORM: personalized pediatric oncology enters the clinic

Lindemann, C

MCP-1 – a critical inducer of Smac mimetic-induced migration and invasion in glioma cells

Linnebacher, M

Analysis and applicability of different in vitro models of Glioblastoma multiforme

Lodrini, M

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

Mariani, L

Phosphoproteomic Analysis of Glioblastoma Reveals Distinct Molecular Subclasses Defined by CREB, NOTCH1 and GSK3b and Different Overall Survival

Mazitschek, R

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

Milde, T

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications
Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

Momma, S

Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB

Nimsky, C

Cell surface metalloproteases as targets in glioblastoma: implications for tumor growth and therapy resistance

Oehme, I

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications
HDAC10: a novel drug target for childhood tumors of the nervous system

Pagenstecher, A

Cell surface metalloproteases as targets in glioblastoma: implications for tumor growth and therapy resistance

Patties, I

Enhancement of radiation effects by combined treatment with 5-aza-2'-deoxycytidine and differentiation-inducing or epigenetic drugs in human MB cells

Pauwels, F

Immunotherapy for children and adults with malignant glioma, the Leuven experiences

Pfister, S

Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications

Pfister, SM

INFORM: personalized pediatric oncology enters the clinic

Pietsch, T

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Rommelaere, J

Treatment approaches combining cytostatic drugs with the oncolytic parvovirus H-1 increase cytotoxic effects in cell culture models of highly malignant pediatric brain tumors

Sailer, M

Phosphoproteomic Analysis of Glioblastoma Reveals Distinct Molecular Subclasses Defined by CREB, NOTCH1 and GSK3b and Different Overall Survival

Schenk, JP

Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

Schlomann, U

Cell surface metalloproteases as targets in glioblastoma: implications for tumor growth and therapy resistance

Seitz, A

Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

Solie, L

Immunotherapy for children and adults with malignant glioma, the Leuven experiences

Strik, H

Cell surface metalloproteases as targets in glioblastoma: implications for tumor growth and therapy resistance

Tchoghandjian, A

Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB

Tostado, C

Phosphoproteomic Analysis of Glioblastoma Reveals Distinct Molecular Subclasses Defined by CREB, NOTCH1 and GSK3b and Different Overall Survival

Vandenberk, L

Irradiation of freeze-thaw lysate used to pulse dendritic cells further increases antitumor immunity in a mouse model of high-grade glioma

Van Gool, S

Immunotherapy for children and adults with malignant glioma, the Leuven experiences
Irradiation of freeze-thaw lysate used to pulse dendritic cells further increases antitumor immunity in a mouse model of high-grade glioma

van Tilburg, C

INFORM: personalized pediatric oncology enters the clinic
Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

Verschuere, T

Irradiation of freeze-thaw lysate used to pulse dendritic cells further increases antitumor immunity in a mouse model of high-grade glioma

Waha, A

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Westphal, C

Treatment approaches combining cytostatic drugs with the oncolytic parvovirus H-1 increase cytotoxic effects in cell culture models of highly malignant pediatric brain tumors

William, D

Analysis and applicability of different in vitro models of Glioblastoma multiforme

Witt, O

INFORM: personalized pediatric oncology enters the clinic
Targeting class I histone deacetylases in high risk medulloblastoma – analysis of molecular mechanisms and translational implications
Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report
Treatment approaches combining cytostatic drugs with the oncolytic parvovirus H-1 increase cytotoxic effects in cell culture models of highly malignant pediatric brain tumors
HDAC10: a novel drug target for childhood tumors of the nervous system

Witt, R

INFORM: personalized pediatric oncology enters the clinic
Phase I/II trial vorinostat in children with relapsed malignancies: interim analysis report

zur Muehlen, A

Molecular genetic analysis of thirty-five diffuse high-grade astrocytomas in children < 3 years of age defines a distinct infant HGG entity

Öztürk, S

Treatment approaches combining cytostatic drugs with the oncolytic parvovirus H-1 increase cytotoxic effects in cell culture models of highly malignant pediatric brain tumors